What is the recommended way to switch a patient from bisoprolol (Bilol) to metoprolol, including equivalent dosing and monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching from Bisoprolol to Metoprolol

Switch by stopping bisoprolol 12 hours before starting metoprolol at half the equivalent dose, then titrate upward every 2 weeks to target dosing. This approach has been validated in heart failure patients and minimizes the risk of clinical deterioration during transition 1.

Equivalent Dosing

The evidence-based target doses for these beta-blockers in heart failure are 2:

  • Bisoprolol: 1.25 mg starting dose → 10 mg once daily target
  • Metoprolol CR/XL: 12.5-25 mg starting dose → 200 mg once daily target

When switching, use approximately 1:20 ratio (bisoprolol to metoprolol). For example:

  • Bisoprolol 10 mg daily ≈ Metoprolol CR/XL 200 mg daily
  • Bisoprolol 5 mg daily ≈ Metoprolol CR/XL 100 mg daily

Switching Protocol

Step 1: Discontinuation Window

  • Stop bisoprolol 12 hours before initiating metoprolol 1
  • This washout period was safely used in 282 heart failure patients without adverse events

Step 2: Initial Metoprolol Dosing

  • Start at 50% of the equivalent dose 3
  • This reduced initial dosing maximizes safety and tolerability
  • For patients on bisoprolol 10 mg: start metoprolol CR/XL at 100 mg daily (not the full 200 mg equivalent)

Step 3: Titration Schedule

  • Increase dose at 2-week intervals minimum 2
  • Double the dose at each step until reaching target
  • Monitor heart rate, blood pressure, and clinical status at each visit
  • Check blood chemistry 1-2 weeks after initiation and after final dose titration

Critical Monitoring Parameters

During the switch, assess for:

  • Heart rate (target reduction to 60-70 bpm range)
  • Blood pressure stability
  • Signs of worsening heart failure (weight gain >1.5-2 kg over 2 days, increased dyspnea, peripheral edema)
  • Symptoms of fatigue or bradycardia

Important Caveats

Do NOT switch if the patient has:

  • Current or recent (within 4 weeks) heart failure exacerbation 2
  • Active signs of congestion (elevated JVP, ascites, marked edema)
  • Heart rate <60 bpm or heart block
  • Unstable clinical status requiring hospitalization

Evidence shows switching FROM carvedilol TO metoprolol carries higher risk than the reverse direction, with a 12.3% event rate versus 3.1% when switching to carvedilol 3. However, switching between bisoprolol and metoprolol appears safer, as both are beta-1 selective agents with similar mortality benefits in matched populations 4.

Problem Management During Switch

If worsening congestion develops:

  • Double the diuretic dose first
  • Only reduce beta-blocker dose if diuretic adjustment fails 2

If marked fatigue or bradycardia occurs:

  • Halve the metoprolol dose temporarily
  • Rarely necessary to discontinue completely

Patient should be instructed to:

  • Weigh daily and report persistent weight gain
  • Not stop beta-blocker without consulting physician
  • Expect potential temporary worsening (occurs in 20-30% of cases) 2
  • Understand symptomatic improvement may take 3-6 months

The key principle is that some beta-blocker is better than no beta-blocker - if target doses cannot be achieved, the highest tolerated dose still provides benefit 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.